Global Information
회사소개 | 문의 | 비교리스트

암치료 : 세계 시장 전망(2018-2027년)

Cancer Therapy - Global Market Outlook (2018-2027)

리서치사 Stratistics Market Research Consulting
발행일 2020년 05월 상품 코드 939149
페이지 정보 영문 140 Pages
가격
US $ 4,150 ₩ 4,757,000 PDF by E-mail (Single User License)
US $ 5,250 ₩ 6,019,000 PDF by E-mail (2-5 User License)
US $ 6,350 ₩ 7,280,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 8,598,000 PDF by E-mail (Global Site License)


암치료 : 세계 시장 전망(2018-2027년) Cancer Therapy - Global Market Outlook (2018-2027)
발행일 : 2020년 05월 페이지 정보 : 영문 140 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암치료 시장은 예측 기간 중 10.4%의 CAGR로 성장할 전망입니다. 시장 성장을 촉진하는 주요 요인에는 정부에 의한 구상의 증가와 기업에 의한 연구개발 구상 등을 들 수 있습니다. 그러나 상환 정책의 변동은 시장 성장을 방해하는 요인입니다.

세계의 암치료 시장에 대해 조사했으며, 시장 기회 및 동향, 성장 및 억제요인, 암 유형·치료 유형·최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 서론

제3장 시장 동향 분석

  • 서론
  • 성장요인
  • 억제요인
  • 시장 기회
  • 위협
  • 최종사용자 분석
  • 신흥 시장
  • 신종 코로나바이러스 감염증의 영향

제4장 Porter의 산업 분석

제5장 세계 시장 : 암 유형별

  • 서론
  • 호흡기/폐암
  • 전립선암
  • 부인과암
  • 소화기암
  • 유방암
  • 혈액암

제6장 세계 시장 : 치료 유형별

  • 서론
  • 표적치료
  • 면역치료
  • 호르몬 요법
  • 화학요법

제7장 세계 시장 : 최종사용자별

  • 서론
  • 암과 방사선 치료 센터
  • 병원
  • 전문 클리닉

제8장 세계 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동·아프리카

제9장 주요 발전

  • 계약, 제휴, 협업, 합병사업
  • 인수합병
  • 신제품 발매
  • 확장
  • 기타 주요 전략

제10장 기업 개요

  • Pfizer Inc
  • Novartis AG
  • Merck & Co Inc
  • Johnson and Johnson
  • F. Hoffmann-La Roche AG
  • Eli Lilly and Company
  • Bayer AG
  • AstraZeneca PLC
  • Amgen Inc
KSA 20.06.12

List of Tables

  • Table 1 Global Cancer Therapy Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 3 Global Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
  • Table 4 Global Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 5 Global Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
  • Table 6 Global Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
  • Table 7 Global Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 8 Global Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
  • Table 9 Global Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
  • Table 10 Global Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
  • Table 11 Global Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
  • Table 12 Global Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
  • Table 13 Global Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 14 Global Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
  • Table 15 Global Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
  • Table 16 Global Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 17 Global Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
  • Table 18 North America Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
  • Table 19 North America Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 20 North America Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
  • Table 21 North America Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 22 North America Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
  • Table 23 North America Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
  • Table 24 North America Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 25 North America Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
  • Table 26 North America Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
  • Table 27 North America Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
  • Table 28 North America Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
  • Table 29 North America Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
  • Table 30 North America Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 31 North America Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
  • Table 32 North America Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
  • Table 33 North America Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 34 North America Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
  • Table 35 Europe Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
  • Table 36 Europe Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 37 Europe Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
  • Table 38 Europe Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 39 Europe Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
  • Table 40 Europe Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
  • Table 41 Europe Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 42 Europe Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
  • Table 43 Europe Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
  • Table 44 Europe Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
  • Table 45 Europe Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
  • Table 46 Europe Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
  • Table 47 Europe Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 48 Europe Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
  • Table 49 Europe Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
  • Table 50 Europe Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 51 Europe Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
  • Table 52 Asia Pacific Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
  • Table 53 Asia Pacific Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 54 Asia Pacific Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
  • Table 55 Asia Pacific Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 56 Asia Pacific Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
  • Table 57 Asia Pacific Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
  • Table 58 Asia Pacific Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 59 Asia Pacific Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
  • Table 60 Asia Pacific Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
  • Table 61 Asia Pacific Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
  • Table 62 Asia Pacific Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
  • Table 63 Asia Pacific Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
  • Table 64 Asia Pacific Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 65 Asia Pacific Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
  • Table 66 Asia Pacific Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
  • Table 67 Asia Pacific Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 68 Asia Pacific Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
  • Table 69 South America Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
  • Table 70 South America Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 71 South America Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
  • Table 72 South America Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 73 South America Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
  • Table 74 South America Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
  • Table 75 South America Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 76 South America Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
  • Table 77 South America Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
  • Table 78 South America Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
  • Table 79 South America Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
  • Table 80 South America Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
  • Table 81 South America Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 82 South America Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
  • Table 83 South America Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
  • Table 84 South America Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 85 South America Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
  • Table 86 Middle East & Africa Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
  • Table 87 Middle East & Africa Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 88 Middle East & Africa Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
  • Table 89 Middle East & Africa Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 90 Middle East & Africa Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
  • Table 91 Middle East & Africa Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
  • Table 92 Middle East & Africa Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 93 Middle East & Africa Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
  • Table 94 Middle East & Africa Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
  • Table 95 Middle East & Africa Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
  • Table 96 Middle East & Africa Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
  • Table 97 Middle East & Africa Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
  • Table 98 Middle East & Africa Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 99 Middle East & Africa Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
  • Table 100 Middle East & Africa Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
  • Table 101 Middle East & Africa Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 102 Middle East & Africa Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)

According to Stratistics MRC, the Global Cancer Therapy Market is expected to grow at a CAGR of 10.4% during the forecast period. Rising initiatives by the government for alertness of cancer and R&D initiatives by the companies are the major factors driving the market growth. However, fluctuation in reimbursement policies is restraining the market growth.

Cancer therapy is the treatment of cancer, mostly done along with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain.

Based on treatment type, the target therapy segment is likely to have a huge demand due to its specificity towards cancer cells. It involves modulators of gene expression, toxin molecules etc. By geography, North America is going to have a lucrative growth during the forecast period due to increase in adoption of this therapy in the emerging economies such as US and increasing occurrences of cancer in the country.

Some of the key players profiled in the Cancer Therapy Market include Pfizer Inc, Novartis AG, Merck & Co Inc, Johnson and Johnson, F. Hoffmann-La Roche AG, Eli Lilly and Company, Bayer AG, AstraZeneca PLC and Amgen Inc.

Cancer Types Covered:

  • Respiratory/Lung Cancer
  • Prostate Cancer
  • Gynecologic Cancer
  • Gastrointestinal Cancer
  • Breast Cancer
  • Blood Cancer

Treatment Types Covered:

  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Chemotherapy

End Users Covered:

  • Cancer and Radiation Therapy Centers
  • Hospitals
  • Specialty Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cancer Therapy Market, By Cancer Type

  • 5.1 Introduction
  • 5.2 Respiratory/Lung Cancer
  • 5.3 Prostate Cancer
  • 5.4 Gynecologic Cancer
  • 5.5 Gastrointestinal Cancer
  • 5.6 Breast Cancer
  • 5.7 Blood Cancer

6 Global Cancer Therapy Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Targeted Therapy
  • 6.3 Immunotherapy
  • 6.4 Hormonal Therapy
  • 6.5 Chemotherapy

7 Global Cancer Therapy Market, By End User

  • 7.1 Introduction
  • 7.2 Cancer and Radiation Therapy Centers
  • 7.3 Hospitals
  • 7.4 Specialty Clinics

8 Global Cancer Therapy Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Pfizer Inc
  • 10.2 Novartis AG
  • 10.3 Merck & Co Inc
  • 10.4 Johnson and Johnson
  • 10.5 F. Hoffmann-La Roche AG
  • 10.6 Eli Lilly and Company
  • 10.7 Bayer AG
  • 10.8 AstraZeneca PLC
  • 10.9 Amgen Inc
Back to Top
전화 문의
F A Q